EUVIMEDEUVIMED entdecken
Crossref

Circulating β-hydroxybutyrate levels are associated with major adverse clinical events in patients with acute myocardial infarction

Yining Dai, Lixin Xie, Yeshen Zhang, Yu He, Haobin Liu, Siyu Kong, Weikun Chen, Hailing Li, Yuling Zhan, Ning Tan, Chongyang Duan, Pengcheng He und 2 weitere

Nutrition, Metabolism and Cardiovascular Diseases · 2025

DOI: 10.1016/j.numecd.2024.10.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2025. Verfasst von Yining Dai und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Souther…. Hauptthemen laut MEDLINE: 3-Hydroxybutyric Acid, Biomarkers, Percutaneous Coronary Intervention, ST Elevation Myocardial Infarction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

3-Hydroxybutyric AcidBiomarkersPercutaneous Coronary InterventionST Elevation Myocardial InfarctionAgedFemaleHumansMaleMiddle AgedHospital MortalityPredictive Value of TestsRetrospective StudiesRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeUp-Regulation

Stichwörter der Autor:innen

Ketone bodiesMajor adverse clinical eventsST-Elevation myocardial infarctionβ-hydroxybutyrate

Substanzen

3-Hydroxybutyric AcidBiomarkers

Autor:innen und Institutionen

  • Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 510080, Guangzhou, China; Guangdong Provincial K…
  • Department of Cardiology, Shangyou People's Hospital, 341299, Ganzhou, China.
  • The Second School of Clinical Medicine, Southern Medical University, 510080, Guangzhou, China.
  • Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China.

Zitieren

APA

Dai, Y., Xie, L., Zhang, Y., He, Y., Liu, H., Kong, S., Chen, W., Li, H., Zhan, Y., Tan, N., Duan, C., He, P., Liu, Y., & Xue, L. (2025). Circulating β-hydroxybutyrate levels are associated with major adverse clinical events in patients with acute myocardial infarction. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2024.10.002

Vancouver

Dai Y, Xie L, Zhang Y, He Y, Liu H, Kong S, et al. Circulating β-hydroxybutyrate levels are associated with major adverse clinical events in patients with acute myocardial infarction. Nutrition, Metabolism and Cardiovascular Diseases. 2025. doi:10.1016/j.numecd.2024.10.002

BibTeX
@article{Dai2025,
  author = {Dai, Yining and Xie, Lixin and Zhang, Yeshen and He, Yu and Liu, Haobin and Kong, Siyu and Chen, Weikun and Li, Hailing and Zhan, Yuling and Tan, Ning and Duan, Chongyang and He, Pengcheng and Liu, Yuanhui and Xue, Ling},
  title = {Circulating β-hydroxybutyrate levels are associated with major adverse clinical events in patients with acute myocardial infarction},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2025},
  doi = {10.1016/j.numecd.2024.10.002}
}
Kostenlos starten →